S. 3105 · 115th Congress
Pharmaceutical Origin Transparency Act of 2018
- Stage
- In committee
- Sponsor
- Claire McCaskill
- Introduced
- 2018-06-21
- Latest action
- 2018-06-21 · Introduced in Senate
Summary
Pharmaceutical Origin Transparency Act of 2018
This bill amends the Federal Food, Drug, and Cosmetic Act to require a drug manufacturer to publish information about each country in which its drugs are manufactured. (A drug is manufactured in a country if the active pharmaceutical ingredient is manufactured in such country.)